BofA downgraded Afya (AFYA) to Neutral from Buy with a price target of $17, down from $22. The firm says the company’s rising investments in non-core businesses will pressure its shareholder returns in the near-term. The analyst now sees a longer than expected ramp-up in Afya’s medical practice solutions.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AFYA: